Concepedia

Mario Torres

MT

Statistics

Publications

16

Citations

1.1K

H-Index

13

Active since

2003

Affiliations

Universidade Federal de Mato Grosso do Sul(Current)

Stanford University

University of Florida

Universidade Estadual de Mato Grosso do Sul

Yale University

Mario Torres is an author at Universidade Federal de Mato Grosso do Sul specializing in infectious diseases, vaccination, and immunization.

ORCID

Publications per year

2003–2022

16

Publications

16

Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study

Otávio T. Ranzani, Matt D. T. Hitchings, Murilo Dorión et al. · BMJ · 2021 · 342 citations · Full text

, , +17

Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study

Matt D. T. Hitchings, Otávio T. Ranzani, Mario Torres et al. · The Lancet Regional Health - Americas · 2021 · 170 citations · Full text

, , +17

Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil

Otávio T. Ranzani, Matt D. T. Hitchings, Rosana Leite de Melo et al. · Nature Communications · 2022 · 115 citations · Full text

, , +17

Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study

Matt D. T. Hitchings, Otávio T. Ranzani, Mario Torres et al. · medRxiv · 2021 · 95 citations · Full text

, , +17

Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo

Matt D. T. Hitchings, Otávio T. Ranzani, Murilo Dorión et al. · Nature Communications · 2021 · 80 citations · Full text

, , +17

1–5 of 16